Scalp-care brand KilgourMD announced reformulated versions of its Prevention and Treatment serums on 12 November 2026. The company says its Prevention serum uses tiny particles of glycogen, a form of stored sugar, to carry basil root extract. Its Treatment serum pairs saw palmetto with a peptide, a short chain of amino acids, in a separate delivery system. KilgourMD via PR Newswire (source, opens in new tab)
KilgourMD via PR NewswireKilgourMD Unveils a New Brand Identity and Next-Generation Scalp Serums Featuring Its First Proprietary Biotechnology ActivesOpen source (opens in new tab)
These technologies are designed to carry ingredients to the scalp and hair follicles, the structures from which hair grows.
KilgourMD reports increased growth in follicles studied outside the body and improved saw-palmetto delivery in skin tests. These are laboratory and tissue findings; the announcement supplies neither the underlying study reports nor clinical results from people using the reformulated serums.
KilgourMD calls the Prevention serum’s delivery technology GlycoRoot. The company reports a 172% relative increase in hair-follicle growth in tests conducted outside the body. The result concerns growth in isolated follicles, rather than the effects of applying the serum to a person’s scalp.
A separate GlycoRoot test measured gene expression: how actively cells use a particular gene. In cells stressed by the hormone testosterone, KilgourMD reports an increase of more than 215% in the activity of a gene called IGF-1. The figure describes a cellular response, not an increase in the amount of hair grown.
The Treatment serum’s delivery technology is called AndroLock. KilgourMD reports 47% enhanced delivery of saw palmetto in tests examining human skin under a microscope. That figure measures ingredient delivery rather than hair growth.
The announcement does not provide detailed methods, sample sizes or controls. Those omissions make the percentages difficult to assess: readers cannot examine what was compared, how the tests were conducted or how consistent the responses were. The announcement describes the new formulas and the company’s laboratory findings without establishing what difference the reformulation makes to someone using the serums.
- KilgourMD via PR Newswire · Company releaseKilgourMD Unveils a New Brand Identity and Next-Generation Scalp Serums Featuring Its First Proprietary Biotechnology Activesprnewswire.com · opens in new tab